Browsing Category
Pharma Industry News
4754 posts
Business-News-Today.com section for global pharma industry news, Indian pharma sector latest news, pharma sector news today, pharmaceuticals industry news.
Breakthrough scar treatment: Innovo Therapeutics’ INV-001 cuts post-thyroidectomy scars by 24.5%
Innovo Therapeutics Inc. has revealed remarkable results from its Phase 2 clinical trial, demonstrating the efficacy of INV-001…
Organon and Eli Lilly expand global reach of migraine treatment Emgality
Organon and Eli Lilly and Company have expanded their commercialization agreement for Emgality, a leading migraine treatment, into…
FDA approves RYBREVANT and LAZCLUZE for EGFR-mutated advanced lung cancer
The U.S. Food and Drug Administration (FDA) has approved the combination of RYBREVANT (amivantamab-vmjw) and LAZCLUZE (lazertinib) as…
This diabetes breakthrough drug slashes risk by 94%—discover how tirzepatide is transforming obesity treatment
Eli Lilly and Company (NYSE: LLY) has released compelling results from the SURMOUNT-1 study, which highlights that tirzepatide…
CARsgen Therapeutics completes enrollment in Phase II trial of Satri-cel for advanced gastric cancer
CARsgen Therapeutics Holdings Limited, a prominent player in the field of CAR T-cell therapies, has announced the successful…
Kineta Inc. resumes VISTA-101 trial enrollment for KVA12123 in advanced solid tumors
Kineta Inc. has announced the resumption of patient enrollment in its VISTA-101 Phase 1/2 clinical trial, which is…
Glenmark Therapeutics takes on Pataday with new OTC eye solution—what you need to know
Glenmark Therapeutics Inc., USA, has launched Olopatadine Hydrochloride Ophthalmic Solution USP, 0.1% (OTC), marking a significant development in…
AbbVie and Genmab’s TEPKINLY approved by EC for advanced lymphoma
AbbVie (NYSE: ABBV) and Genmab (NASDAQ: GMAB) have announced that the European Commission (EC) has granted conditional marketing…
Breakthrough in cancer treatment: China approves PADCEV for advanced urothelial cancer
China’s National Medical Products Administration (NMPA) has granted approval for PADCEV (enfortumab vedotin) to treat locally advanced or…
Sequent Scientific secures WHO prequalification for Albendazole API
Sequent Scientific Limited, a leading Indian pharmaceutical company, has achieved a significant milestone by securing prequalification (PQ) approval…